Proteomics and Genomics
Proteomics is a large study of proteome. A proteome is a set of proteins produced in an organism, system, or biological situation. For example, it can represent a proteome of a species (such as Homo sapiens) or an organ (such as the liver). Proteome is not constant. It varies from cell to cell and changes over time. To some degree, the proteome reflects the underlying transcriptome. However, protein activity (often measured by the kinetics of processes involving proteins) is regulated by many factors, in addition to the expression level of the relevant gene.
Genomics is a department of biotechnology concerned with applying the procedures of genetics and atomic science to the hereditary mapping and DNA sequencing of sets of qualities or the total genomes of selected living beings, with organizing the results in databases, and with applications of the information (as in pharmaceutical or science)
Related Conference of Proteomics and Genomics
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Proteomics and Genomics Conference Speakers
Recommended Sessions
- Biomarkers
- Cancer Epigenetics
- Cardiovascular Proteomics
- Clinical Genomics & Clinical Proteomics
- Computational Biology, Bioinformatics, and Biostatistics
- Computing in Biomedicine and Genomics
- E-Health, Telemedicine
- Genome Projects and Genome Sequencing
- Immunogenetics and Immunology
- Metabolomics and Metabonomics
- Metabolomics in Precision Medicine
- Modern Genetics
- Pharmacogenomics
- Protein Interactions in Biology
- Proteomics and Genomics
- Proteomics and its Medicinal Research
- Proteomics Technologies
- Signaling/Computational Biomedical Data Engineering
- Stem Cell Proteomics
- Toxicogenomics and Pharmacoproteomics
- Transcriptomics
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)